Calithera_Logo_Primary_RGB_M01.jpg
Updated Results from Phase I Study of CB-839 in Combination with Paclitaxel in Patients with Triple Negative Breast Cancer to be Presented at the 2017 San Antonio Breast Cancer Symposium
05. Dezember 2017 08:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on discovering and developing novel small...
livingbeyondbreastcancer
Living Beyond Breast Cancer to Host
08. Juli 2015 09:07 ET | Living Beyond Breast Cancer
PHILADELPHIA, PA., July 8, 2015 (GLOBE NEWSWIRE) -- In a brand new format to provide both information and support, Living Beyond Breast Cancer (LBBC) has announced that registration is now open for...
livingbeyondbreastcancer
Hot topics in breast cancer this Spring from LBBC
26. Februar 2015 11:26 ET | Living Beyond Breast Cancer
HAVERFORD, PA., Feb. 26, 2015 (GLOBE NEWSWIRE) -- This spring, Living Beyond Breast Cancer (LBBC) releases research, hosts events, and publishes guides that help inform and support individuals who may...